Cargando…
Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy
OBJECTIVE: The purpose of this study was to investigate the target dose discrepancy caused by intrafraction variation during stereotactic body radiotherapy (SBRT) for lung cancer. METHODS: Intensity-modulated radiation therapy (IMRT) plans were designed based on average computed tomography (AVG CT)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987420/ https://www.ncbi.nlm.nih.gov/pubmed/36891502 http://dx.doi.org/10.3389/fonc.2022.1010411 |
_version_ | 1784901382321471488 |
---|---|
author | Han, Bin Wu, Bian Hu, Fala Ma, Yangguang Wang, Haiyang Han, Xinwei Liu, Gang Guo, Yuexin |
author_facet | Han, Bin Wu, Bian Hu, Fala Ma, Yangguang Wang, Haiyang Han, Xinwei Liu, Gang Guo, Yuexin |
author_sort | Han, Bin |
collection | PubMed |
description | OBJECTIVE: The purpose of this study was to investigate the target dose discrepancy caused by intrafraction variation during stereotactic body radiotherapy (SBRT) for lung cancer. METHODS: Intensity-modulated radiation therapy (IMRT) plans were designed based on average computed tomography (AVG CT) utilizing the planning target volume (PTV) surrounding the 65% and 85% prescription isodoses in both phantom and patient cases. Variation was simulated by shifting the nominal plan isocenter along six directions from 0.5 mm to 4.5 mm with a 1-mm step size to produce a series of perturbed plans. The dose discrepancy between the initial plan and the perturbed plans was calculated as the percentage of the initial plan. Dose indices, including ΔD(99) for internal target volume (ITV) and gross tumor volume (GTV), were adopted as endpoint samples. The mean dose discrepancy was calculated under the 3-dimensional space distribution. RESULTS: We found that motion can lead to serious dose degradation of the target and ITV in lung SBRT, especially during SBRT with PTV surrounding the lower isodose line. Lower isodose line may lead to larger dose discrepancy, while make steeper dose fall-off gradient. This phenomenon was compromised when 3-dimensional space distribution was considered. DISCUSSION: This result may provide a prospective reference for target dose degradation due to motion during lung SBRT treatment. |
format | Online Article Text |
id | pubmed-9987420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99874202023-03-07 Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy Han, Bin Wu, Bian Hu, Fala Ma, Yangguang Wang, Haiyang Han, Xinwei Liu, Gang Guo, Yuexin Front Oncol Oncology OBJECTIVE: The purpose of this study was to investigate the target dose discrepancy caused by intrafraction variation during stereotactic body radiotherapy (SBRT) for lung cancer. METHODS: Intensity-modulated radiation therapy (IMRT) plans were designed based on average computed tomography (AVG CT) utilizing the planning target volume (PTV) surrounding the 65% and 85% prescription isodoses in both phantom and patient cases. Variation was simulated by shifting the nominal plan isocenter along six directions from 0.5 mm to 4.5 mm with a 1-mm step size to produce a series of perturbed plans. The dose discrepancy between the initial plan and the perturbed plans was calculated as the percentage of the initial plan. Dose indices, including ΔD(99) for internal target volume (ITV) and gross tumor volume (GTV), were adopted as endpoint samples. The mean dose discrepancy was calculated under the 3-dimensional space distribution. RESULTS: We found that motion can lead to serious dose degradation of the target and ITV in lung SBRT, especially during SBRT with PTV surrounding the lower isodose line. Lower isodose line may lead to larger dose discrepancy, while make steeper dose fall-off gradient. This phenomenon was compromised when 3-dimensional space distribution was considered. DISCUSSION: This result may provide a prospective reference for target dose degradation due to motion during lung SBRT treatment. Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9987420/ /pubmed/36891502 http://dx.doi.org/10.3389/fonc.2022.1010411 Text en Copyright © 2022 Han, Wu, Hu, Ma, Wang, Han, Liu and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Han, Bin Wu, Bian Hu, Fala Ma, Yangguang Wang, Haiyang Han, Xinwei Liu, Gang Guo, Yuexin Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
title | Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
title_full | Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
title_fullStr | Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
title_full_unstemmed | Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
title_short | Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
title_sort | simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987420/ https://www.ncbi.nlm.nih.gov/pubmed/36891502 http://dx.doi.org/10.3389/fonc.2022.1010411 |
work_keys_str_mv | AT hanbin simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT wubian simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT hufala simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT mayangguang simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT wanghaiyang simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT hanxinwei simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT liugang simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy AT guoyuexin simulationofdosimetricconsequencesofintrafractionvariationoftumordriftinlungcancerstereotacticbodyradiotherapy |